David C. Hooper
Impact in
- Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria
- Applied Microbiology and Biotechnology top 0.05%
Papers in
-
- Antibiotic Resistance in Bacteria 143
- Pharmacology 90
- Antibiotics Pharmacokinetics and Efficacy 86
- Co-authors
- George A. Jacoby (45 shared papers)John S. Wolfson (40 shared papers)Ari A. Robicsek (9 shared papers)Jacob Strahilevitz (15 shared papers)Anton Yariv Peleg (1 shared paper)Chi Hye Park (8 shared papers)Que Chi Truong-Bolduc (28 shared papers)E Y Ng (9 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (78 papers)Clinical Infectious Diseases (29 papers)Journal of Bacteriology (20 papers)Infection Control and Hospital Epidemiology (18 papers)Open Forum Infectious Diseases (8 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
David C. Hooper
296 papers receiving 25.5k citations
David C. Hooper's Hit Papers
Peers
Comparison fields: 5 of 187
- Molecular Medicine 13.3k
- Applied Microbiology and Biotechnology 1.4k
- Endocrinology 3.4k
- Pharmacology 6.8k
- Clinical Biochemistry 2.1k
Countries citing papers authored by David C. Hooper
This map shows the geographic impact of David C. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Hooper more than expected).
Fields of papers citing papers by David C. Hooper
This network shows the impact of papers produced by David C. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Hooper. The network helps show where David C. Hooper may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Hooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 298 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hospital-Acquired Infections Due to Gram-Negative Bacteria Hit paper breakdown → | 2010 | 1202 |
| 2 | Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase Hit paper breakdown → | 2005 | 836 |
| 3 | The worldwide emergence of plasmid-mediated quinolone resistance Hit paper breakdown → | 2006 | 804 |
| 4 | Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat Hit paper breakdown → | 2009 | 787 |
| 5 | Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy Hit paper breakdown → | 1991 | 782 |
| 6 | Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme Hit paper breakdown → | 2006 | 670 |
| 7 | The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro Hit paper breakdown → | 1985 | 640 |
| 8 | Fluoroquinolone antimicrobial agents Hit paper breakdown → | 1989 | 559 |
| 9 | Mechanisms of drug resistance: quinolone resistance Hit paper breakdown → | 2015 | 526 |
| 10 | 2006 | 510 | |
| 11 | 2001 | 499 | |
| 12 | 1991 | 495 | |
| 13 | Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents Hit paper breakdown → | 2018 | 471 |
| 14 | 2003 | 421 | |
| 15 | 2001 | 412 | |
| 16 | 1999 | 398 | |
| 17 | 2008 | 382 | |
| 18 | 2014 | 378 | |
| 19 | 1985 | 369 | |
| 20 | 2006 | 361 |
About David C. Hooper
David C. Hooper is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Molecular Biology and Clinical Biochemistry, having authored 298 papers that have together received 27.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (143 papers), Antibiotics Pharmacokinetics and Efficacy (86 papers), Antimicrobial Resistance in Staphylococcus (70 papers), Cancer therapeutics and mechanisms (70 papers), Bacterial Genetics and Biotechnology (28 papers), Bacterial Identification and Susceptibility Testing (21 papers), Bacterial biofilms and quorum sensing (18 papers) and Pneumonia and Respiratory Infections (17 papers). The work is most often cited by research in Molecular Medicine (13.3k citations), Applied Microbiology and Biotechnology (1.4k citations), Endocrinology (3.4k citations), Pharmacology (6.8k citations) and Clinical Biochemistry (2.1k citations). David C. Hooper has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include George A. Jacoby, John S. Wolfson, Ari A. Robicsek, Jacob Strahilevitz, Anton Yariv Peleg, Chi Hye Park, Que Chi Truong-Bolduc, E Y Ng, Bénédicte Fournier and Michele Trucksis. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Journal of Bacteriology, Infection Control and Hospital Epidemiology and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.